Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA
55 results:

  • 1. Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment.
    Qiu L; Shen R; Wei L; Xu S; Xia W; Hou Y; Cui J; Qu R; Luo J; Cao J; Yang J; Sun J; Ma R; Yu Q
    J Nanobiotechnology; 2023 Sep; 21(1):344. PubMed ID: 37741962
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis.
    Hyung J; Lee JY; Kim JE; Yoon S; Yoo C; Hong YS; Jeong JH; Kim TW; Jeon S; Jun HR; Jung CK; Jang JP; Kim J; Chun SM; Ahn JH
    ESMO Open; 2023 Jun; 8(3):101583. PubMed ID: 37327700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. RNA Sequencing Identifies Novel nrg1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
    Severson E; Achyut BR; Nesline M; Pabla S; Previs RA; Kannan G; Chenn A; Zhang S; Klein R; Conroy J; Sausen M; Sathyan P; Saini KS; Ghosh A; Jensen TJ; Reddy P; Ramkissoon SH
    J Mol Diagn; 2023 Jul; 25(7):454-466. PubMed ID: 37164276
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma.
    Desai O; Wang R
    Oncotarget; 2023 May; 14():439-443. PubMed ID: 37163206
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth.
    Lemmetyinen TT; Viitala EW; Wartiovaara L; Kaprio T; Hagström J; Haglund C; Katajisto P; Wang TC; Domènech-Moreno E; Ollila S
    Dis Model Mech; 2023 Apr; 16(4):. PubMed ID: 36912192
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dual-targeting therapy against HER3/MET in human colorectal cancers.
    Yamasaki A; Miyake R; Hara Y; Okuno H; Imaida T; Okita K; Okazaki S; Akiyama Y; Hirotani K; Endo Y; Masuko K; Masuko T; Tomioka Y
    Cancer Med; 2023 Apr; 12(8):9684-9696. PubMed ID: 36751113
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
    Garcia-Rendueles MER; Krishnamoorthy G; Saqcena M; Acuña-Ruiz A; Revilla G; de Stanchina E; Knauf JA; Lester R; Xu B; Ghossein RA; Fagin JA
    Mol Cancer; 2022 Dec; 21(1):213. PubMed ID: 36476495
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A novel nomogram associated with regulatory T cells infiltration by weighted gene co-expression network analysis for predicting survival in patients with colon cancer.
    Li HJ; Peng JK; Wang YQ; Jiang HW; Wang J
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):8073-8086. PubMed ID: 36394757
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Blood Serum Zonulin in colorectal cancer, Autoimmune Bowel Diseases, and Irritable Bowel Syndrome.
    Kushlinskii NE; Gershtein ES; Zybina NN; Tsarapaev PV; Salyanova EP; Korotkova EA; Nikonov EL; Mamedli ZZ; Bozhenko VK; Stilidi IS
    Bull Exp Biol Med; 2022 Jul; 173(3):376-379. PubMed ID: 35852686
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer.
    Cao L; Ba Y; Yang J; Zhang H
    Aging (Albany NY); 2022 Jun; 14(12):5131-5152. PubMed ID: 35748788
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Application of histology-agnostic treatments in metastatic colorectal cancer.
    Sartore-Bianchi A; Agostara AG; Patelli G; Mauri G; Pizzutilo EG; Siena S
    Dig Liver Dis; 2022 Oct; 54(10):1291-1303. PubMed ID: 35701319
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Assessment of Textbook Oncologic Outcomes Following Proctectomy for Rectal cancer.
    Naffouje SA; Ali MA; Kamarajah SK; White B; Salti GI; Dahdaleh F
    J Gastrointest Surg; 2022 Jun; 26(6):1286-1297. PubMed ID: 35441331
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Role of Autophagy in Tumor Immune Infiltration in colorectal cancer.
    Bian-Fang Y; Dong-Ning W; Dan T; Jian-Yu S; Shi-Yi W; Ben-Jun W; Xin D; Wen-Wen Z; Qing-Feng W; Yan Z
    Anal Cell Pathol (Amst); 2022; 2022():2055676. PubMed ID: 35321516
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Early postoperative pain as a marker of anastomotic leakage in colorectal cancer surgery.
    Boström P; Svensson J; Brorsson C; Rutegård M
    Int J Colorectal Dis; 2021 Sep; 36(9):1955-1963. PubMed ID: 34272996
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic alteration of Chinese patients with rectal mucosal melanoma.
    Li H; Yang L; Lai Y; Wang X; Han X; Liu S; Wang D; Li X; Hu N; Kong Y; Si L; Li Z
    BMC Cancer; 2021 May; 21(1):623. PubMed ID: 34044811
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories.
    Bocciarelli C; Caumont C; Samaison L; Cariou M; Aline-Fardin A; Doucet L; Roudié J; Terris B; Merlio JP; Marcorelles P; Cappellen D; Uguen A
    Hum Pathol; 2021 Aug; 114():99-109. PubMed ID: 34019865
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anal squamous cell carcinoma: a retrospective case series.
    Houlihan OA; Monaghan O; O'Sullivan S; Nugent K; Dunne M; Neary P; Cahill R; Mehigan B; McNamara DA; Salib O; Gillham C; McVey G; Faul C; Cunningham M; Armstrong J; O'Neill BDP
    Ir J Med Sci; 2022 Apr; 191(2):681-686. PubMed ID: 33977391
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epithelium-derived Indian Hedgehog restricts stromal expression of ErbB family members that drive colonic tumor cell proliferation.
    Westendorp F; Karpus ON; Koelink PJ; Vermeulen JLM; Meisner S; Koster J; Büller NVJA; Wildenberg ME; Muncan V; van den Brink GR
    Oncogene; 2021 Mar; 40(9):1628-1643. PubMed ID: 33479497
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Corosolic acid inhibits colorectal cancer cells growth as a novel HER2/HER3 heterodimerization inhibitor.
    Zhang BY; Zhang L; Chen YM; Qiao X; Zhao SL; Li P; Liu JF; Wen X; Yang J
    Br J Pharmacol; 2021 Mar; 178(6):1475-1491. PubMed ID: 33443775
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Therapeutic Potential of Afatinib in nrg1 Fusion-Driven Solid Tumors: A Case Series.
    Cadranel J; Liu SV; Duruisseaux M; Branden E; Goto Y; Weinberg BA; Heining C; Schlenk RF; Cheema P; Jones MR; Drilon A; Trombetta D; Muscarella LA; Tolba K; Gounant V; Cseh A; Solca F; Laskin JJ; Renouf DJ
    Oncologist; 2021 Jan; 26(1):7-16. PubMed ID: 32852072
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.